This company listing is no longer active
CLS UR B Stock Overview
Engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Clinical Laserthermia Systems AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 0.0002 |
52 Week High | SEK 0.16 |
52 Week Low | SEK 0.0002 |
Beta | 0.91 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -99.78% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
CLS UR B | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | -95.8% | 0.6% | 1.6% |
1Y | n/a | 22.1% | 25.5% |
Return vs Industry: Insufficient data to determine how CLS UR B performed against the Swedish Medical Equipment industry.
Return vs Market: Insufficient data to determine how CLS UR B performed against the Swedish Market.
Price Volatility
CLS UR B volatility | |
---|---|
CLS UR B Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.6% |
Market Average Movement | 5.6% |
10% most volatile stocks in SE Market | 11.6% |
10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: CLS UR B's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine CLS UR B's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 12 | Dan Mogren | www.clinicallaser.se |
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment.
Clinical Laserthermia Systems AB (publ) Fundamentals Summary
CLS UR B fundamental statistics | |
---|---|
Market cap | SEK 22.31m |
Earnings (TTM) | -SEK 78.28m |
Revenue (TTM) | SEK 6.15m |
3.6x
P/S Ratio-0.3x
P/E RatioIs CLS UR B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CLS UR B income statement (TTM) | |
---|---|
Revenue | SEK 6.15m |
Cost of Revenue | SEK 8.58m |
Gross Profit | -SEK 2.43m |
Other Expenses | SEK 75.85m |
Earnings | -SEK 78.28m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Aug 25, 2023
Earnings per share (EPS) | -0.48 |
Gross Margin | -39.53% |
Net Profit Margin | -1,273.45% |
Debt/Equity Ratio | 0% |
How did CLS UR B perform over the long term?
See historical performance and comparison